---
title: "Sinopharm Tech Holdings Limited (08156.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/08156.HK.md"
symbol: "08156.HK"
name: "Sinopharm Tech Holdings Limited"
industry: "Health Care Distributors"
---

# Sinopharm Tech Holdings Limited (08156.HK)

| Item | Detail |
|------|--------|
| Industry | Health Care Distributors |
| Location | HK Market |
| Website | [www.sinopharmtech.com.hk](https://www.sinopharmtech.com.hk) |

## Company Profile

Sinopharm Tech Holdings Limited, an investment holding company, engages in trading of medical and related products in China. It is involved in the provision of Internet plus solution services, including provision of internet related solution services; and manufacturing and distribution of personal p...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-15T04:30:11.000Z

**Overall: C (0.47)**

**Industry**: Health Care Distributors

| Metric | Value |
|--------|-------|
| Industry Ranking | 13 / 21 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 48.39% |  |
| Net Profit YoY | 95.60% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | -4.73 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 174.23M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 61.24M |  |


**Multi Score**: C

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 0.49% | D |
| Profit Margin | -1.42% | D |
| Gross Margin | 23.23% | D |

#### Growth Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 48.39% | A |
| Net Profit YoY | 95.60% | A |
| Total Assets YoY | 16.29% | A |
| Net Assets YoY | 82.15% | A |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -7064.94% | E |
| OCF YoY | 48.39% | A |

#### Operating Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 1.27 | A |

#### Debt Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 170.93% | E |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Sinopharm Tech Holdings Limited",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "0.49%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-1.42%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "23.23%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "A",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "48.39%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "95.60%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "16.29%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "82.15%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-7064.94%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "48.39%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "A",
      "indicators": [
        {
          "name": "Turnover",
          "value": "1.27",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "E",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "170.93%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | YSB (HK.9885) | C | B | A | D | B | B |
| 02 | GUANZE MEDICAL (HK.2427) | B | A | C | A | B | B |
| 03 | GBG HOLDINGS (HK.8372) | B | B | B | A | B | B |
| 04 | SH PHARMA (HK.2607) | C | C | A | D | B | C |
| 05 | BAIYUNSHAN PH (HK.874) | C | C | A | C | B | C |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -201.00 | 22/23 | - | - | - |
| PB | -4.73 | 21/23 | - | - | - |
| PS (TTM) | 2.85 | 20/23 | 3.52 | 3.05 | 1.84 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/08156.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/08156.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/08156.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
